Pfizer Stock: How to Trade the Latest Price Action
Dec 8, 2021
Shares in Pfizer (PFE) saw two-sided action this week after news surfaced that three doses of its Covid-19 vaccine show promising results against the Omicron variant.
Pfizer continues to outpace the S&P Healthcare (XLV), with returns almost double that of the sector.
Regarding trading opportunity, Pfizer now has an implied volatility rank of 73, with a raw implied volatility of 39%, more than twice that of the sector ETF.
Trader’s may be hesitant of picking a price direction in Pfizer given its meteoric rise this year and the possibility for major Covid media developments to jolt the stock one way or another. Options traders can overcome this analysis paralysis by utilizing strategies that could profit regardless of price direction.
Today’s Alpha Boost email from Quiet Foundation included two strategies that could fit this mentality. The first is a put ratio spread, combining one long put option with two short put options to create a position that is net bullish (positive delta) but could profit more from a fall in the stock price.
The 50 / 49 put ratio (buying the 50 put and selling two 49 puts) collects $104 in premium but could profit as much as $204 of the stock price falls to $49 by expiration. While the trade is short two put options, the long option at a higher strike creates a debit spread resulting in the net risk of only one put.
Similar to the ratio spread, the put broken wing butterfly could be profitable in all three scenarios of price direction. The butterfly adds another long put option, capping the risk on the trade.
This trade idea is the same as the ratio above but adds the purchase of the 46 put to make the maximum loss on the trade $161, while lowering the premium to $39 and the max profit to $139. Again, the maximum profit would only be realized if PFE is at $49 at January expiration.
Traders interested in other stocks related to vaccine treatments could look for opportunities in Covid-19 drug makers could look into Moderna (MRNA) or Merck (MRK) which respectively produce vaccines and antiviral drugs. It’s worth noting that Pfizer makes up 5.7% of the portfolio held by XLV, while Merck constitutes 3.6% and Moderna 1.9%.
Options involve risk and are not suitable for all investors. Please read Characteristics and Risks of Standardized Options before deciding to invest in options.
tastytrade content is provided solely by tastytrade, Inc. (“tastytrade”) and is for informational and educational purposes only. It is not, nor is it intended to be, trading or investment advice or a recommendation that any security, futures contract, transaction or investment strategy is suitable for any person. Trading securities can involve high risk and the loss of any funds invested. tastytrade, through its content, financial programming or otherwise, does not provide investment or financial advice or make investment recommendations. Investment information provided may not be appropriate for all investors, and is provided without respect to individual investor financial sophistication, financial situation, investing time horizon or risk tolerance. tastytrade is not in the business of transacting securities trades, nor does it direct client commodity accounts or give commodity trading advice tailored to any particular client’s situation or investment objectives. Supporting documentation for any claims (including claims made on behalf of options programs), comparison, statistics, or other technical data, if applicable, will be supplied upon request. tastytrade is not a licensed financial advisor, registered investment advisor, or a registered broker-dealer. Options, futures and futures options are not suitable for all investors. Prior to trading securities products, please read the Characteristics and Risks of Standardized Options and the Risk Disclosure for Futures and Options found on tastyworks.com.
tastytrade is a trademark/servicemark owned by tastytrade.
tastyworks, Inc. ("tastyworks") is a registered broker-dealer and member of FINRA, NFA and SIPC. tastyworks offers self-directed brokerage accounts to its customers. tastyworks does not give financial or trading advice nor does it make investment recommendations. You alone are responsible for making your investment and trading decisions and for evaluating the merits and risks associated with the use of tastyworks’ systems, services or products. tastyworks is a wholly owned subsidiary of tastytrade, Inc (“tastytrade”).
tastyworks, Inc. (“tastyworks”) has entered into a Marketing Agreement with tastytrade (“Marketing Agent”) whereby tastyworks pays compensation to Marketing Agent to recommend tastyworks’ brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastyworks. tastytrade is the parent company of tastyworks. tastyworks and Marketing Agent are separate entities with their own products and services. tastytrade has different privacy policies than tastyworks.
Quiet Foundation, Inc. (“Quiet Foundation”) is a wholly-owned subsidiary of tastytrade The information on quietfoundation.com is intended for U.S. residents only. All investing involves the risk of loss. Past performance is not a guarantee of future results. Quiet Foundation does not make suitability determinations, nor does it make investment recommendations. You alone are responsible for making your investment and trading decisions and for evaluating the merits and risks associated with the use of Quiet Foundation’s systems, services or products.
Small Exchange, Inc. is a Designated Contract Market registered with the U.S. Commodity Futures Trading Commission. The information on this site should be considered general information and not in any case as a recommendation or advice concerning investment decisions. The reader itself is responsible for the risks associated with an investment decision based on the information stated in this material in light of his or her specific circumstances. The information on this website is for informational purposes only, and does not contend to address the financial objectives, situation, or specific needs of any individual investor. Trading in derivatives and other financial instruments involves risk, please read the Risk Disclosure Statement for Futures and Options. tastytrade is an investor in Small Exchange, Inc.